The existence of a core haplotype shared among all carriers of the variant, independently of the cancer type, matching the conserved region previously identified in the high-density SNP analysis, strongly corroborates a founder effect in the CHEK2 variant c.349A>G. Here, CHEK2 is linked to cancer.